Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Virgin returns to the ASX: Buy the hype or wait for a dip?

The return of Virgin Australia to the ASX is one of the most anticipated IPOs of 2025. With Bain Capital reducing its stake...
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Woodside breaks out: Is this the start of a long-awaited rerating?

Woodside Energy just got the green light it’s been chasing for years: The extension of its Northwest Shelf gas project through to 2070....
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Australia stands tall: RBA cuts rates as US credit rating slips

With the RBA announcing a 25-basis point rate cut, the nation’s economic future just got a little brighter.
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Trump’s tariff bombshell sends markets spinning. Opportunity or orchestration?

Donald Trump’s latest tariff bombshell has shaken global markets and it’s raising serious questions. Was this chaos just bad policy…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Market turmoil: Are Trump’s tariffs a repeat of the 1930s trade war?

Donald Trump’s latest wave of tariffs is sending shockwaves through world economies, drawing comparisons to the infamous Smoot-Hawley Tariff Act of the 1930s.
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Big pharma targets Australia. Could tariffs break the market?

What if the cost of life-saving medicine in Australia skyrocketed overnight – all because of a trade war?